Try our beta test site
1 study found for:    20937112 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
Condition: Multiple Sclerosis
Interventions: Drug: Fingolimod 1.25 mg;   Drug: Fingolimod 0.5 mg;   Drug: Interferon β-1a 30 µg

Study has passed its completion date and status has not been verified in more than two years.